These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36613765)

  • 21. Circulating levels of citrullinated and MMP-degraded vimentin (VICM) in liver fibrosis related pathology.
    Vassiliadis E; Oliveira CP; Alvares-da-Silva MR; Zhang C; Carrilho FJ; Stefano JT; Rabelo F; Pereira L; Kappel CR; Henriksen K; Veidal SS; Vainer B; Duffin KL; Christiansen C; Leeming DJ; Karsdal M
    Am J Transl Res; 2012; 4(4):403-14. PubMed ID: 23145208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum sirtuin-1 a potential marker in the diagnosis of rheumatoid arthritis.
    Tan L; Ouyang T; Li X; Chen Y; Ke S; Chen J; Liu Y; Zeng F; Chen Y; Long J; Deng Q; Hu X
    Autoimmunity; 2023 Dec; 56(1):2181234. PubMed ID: 36843438
    [No Abstract]   [Full Text] [Related]  

  • 23. Meta-analysis: compared with anti-CCP and rheumatoid factor, could anti-MCV be the next biomarker in the rheumatoid arthritis classification criteria?
    Zhu JN; Nie LY; Lu XY; Wu HX
    Clin Chem Lab Med; 2019 Oct; 57(11):1668-1679. PubMed ID: 31141478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Citrullinated Antigens with Multiple Citrulline Similar Motif in the Diagnosis of Rheumatoid Arthritis: A Preliminary Single-Center Study.
    Chen Z; Fang W; Qin Y; Jin YZ; Yang X; Lou J
    J Immunol Res; 2021; 2021():1891519. PubMed ID: 34423050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis.
    Grönwall C; Liljefors L; Bang H; Hensvold AH; Hansson M; Mathsson-Alm L; Israelsson L; Joshua V; Svärd A; Stålesen R; Titcombe PJ; Steen J; Piccoli L; Sherina N; Clavel C; Svenungsson E; Gunnarsson I; Saevarsdottir S; Kastbom A; Serre G; Alfredsson L; Malmström V; Rönnelid J; Catrina AI; Lundberg K; Klareskog L
    Front Immunol; 2021; 12():627986. PubMed ID: 34093522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
    Snir O; Widhe M; Hermansson M; von Spee C; Lindberg J; Hensen S; Lundberg K; Engström A; Venables PJ; Toes RE; Holmdahl R; Klareskog L; Malmström V
    Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years.
    da Mota LM; Dos Santos Neto LL; de Carvalho JF; Pereira IA; Burlingame R; Ménard HA; Laurindo IM
    Rheumatol Int; 2012 Dec; 32(12):3807-12. PubMed ID: 22187055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Independence of carbohydrate-deficient isoforms of transferrin and cyclic citrullinated peptides in rheumatoid arthritis.
    Gudowska M; Gindzienska-Sieskiewicz E; Gruszewska E; Cylwik B; Sierakowski S; Szmitkowski M; Chrostek L
    Rev Bras Reumatol Engl Ed; 2017; 57(3):185-189. PubMed ID: 28535888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative evaluation of treatment patterns and healthcare utilization of newly-diagnosed rheumatoid arthritis patients by anti-cyclic citrullinated peptide antibody status.
    Lamerato L; Price K; Szymialis R; Eaddy M; Ogbonnaya A; Shih HC; Ahmad H
    J Med Econ; 2018 Mar; 21(3):231-240. PubMed ID: 29027497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Significance and diagnostic value of synovial fluid anti-cyclic citrullinated peptide antibody and anti-mutated citrullinated vimentin antibodies in patients with serum negative rheumatoid arthritis].
    Qu SJ; Ye H; Jia RL; Li ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):933-936. PubMed ID: 27987492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-mutated citrullinated vimentin antibodies in rheumatoid arthritis; diagnostic utility and association with deformities and disease activity.
    Mohammed HS; Ahmed GH; Tawfik NM; Sayed SK; Ahmed AS
    Egypt J Immunol; 2023 Jan; 30(1):105-115. PubMed ID: 36592386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
    Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
    J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis.
    Wagner E; Skoumal M; Bayer PM; Klaushofer K
    Rheumatol Int; 2009 Sep; 29(11):1315-21. PubMed ID: 19184032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Value of Detecting Anti-Mutated Citrullinated Vimentin, Anti-Cyclic Citrullinated Peptide, Red Cell Distribution Width and 25-Hydroxyvitamin D in the Diagnosis of Rheumatoid Arthritis.
    Tan L; Gong Y; Zhang Q; Zhang H; Lu X; Huang H
    Lab Med; 2021 Jan; 52(1):80-85. PubMed ID: 32729616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Citrullinated and MMP-degraded vimentin is associated with chronic pulmonary diseases and genetic variants in PADI3/PADI4 and CFH in postmenopausal women.
    Bager CL; Blair JPM; Tang ME; Mortensen JH; Bay-Jensen AC; Frederiksen P; Leeming D; Christiansen C; Karsdal MA
    Sci Rep; 2023 Dec; 13(1):23039. PubMed ID: 38155185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic performance of a new vimentin-derived ACPA (CCP high sensitive) in patients with rheumatoid arthritis.
    Bertin D; Dubucquoi S; Lakomy D; Deleplancque AS; Desplat-Jégo S
    Immunol Res; 2016 Apr; 64(2):455-60. PubMed ID: 26350265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis.
    Barouta G; Katsiari CG; Alexiou I; Liaskos C; Varna A; Bogdanos DP; Germenis AE; Sakkas LI
    Clin Rheumatol; 2017 Apr; 36(4):885-894. PubMed ID: 27943044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of anti-mutated citrullinated vimentin antibodies in diagnosing rheumatoid arthritis.
    Sghiri R; Bouajina E; Bargaoui D; Harzallah L; Fredj HB; Sammoud S; Ghedira I
    Rheumatol Int; 2008 Nov; 29(1):59-62. PubMed ID: 18496693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
    van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D
    Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic value of the anti-Sa antibody compared with the anti-cyclic citrullinated peptide antibody in rheumatoid arthritis.
    Iwaszkiewicz C; Puszczewicz M; Białkowska-Puszczewicz G
    Int J Rheum Dis; 2015 Jan; 18(1):46-51. PubMed ID: 25488711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.